362
Participants
Start Date
May 31, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
olmesartan medoxomil
"Cohorts A and B: 2.5mg to 40mg olmesartan, as a suspension (depending on weight), once daily. Tablets were used to prepare a suspension.~Cohort C: 0.3mg/kg olmesartan ,as a suspension, once daily"
placebo
Cohorts A, B, C: placebo, once daily
olmesartan medoxomil
"Cohorts A and B: Open label olmesartan medoxomil suspension or tablets 10mg - 40 mg. Tablets were used to prepare the suspension or were given directly.~Cohort C: Open label olmesartan medoxomil suspension 0.3 mg/kg - 0.6 mg/kg"
Eastern Cape
Western Cape
Cape Town
Bloemfontein
Tampa
Phoenix
Los Angeles
Birmingham
Little Rock
Beverly Hills
Fresno
Washington D.C.
Jacksonville
Miami
Orlando
Decatur
Honolulu
Park Ridge
New Orleans
Shreveport
Baltimore
Grand Rapids
Las Vegas
Hackensack
New Brunswick
Kinston
Cincinnati
Dayton
Portland
Beaumont
Houston
Charlottesville
San Miguel de Tucumán
Bahía Blanca
Buenos Aires
Capital Federal
Mar del Plata
Campinas
Curitiba
Porto Alegre
Recife
São Paulo
Santiago
Bogotá
Cali-Valle
Ahmedabad
Mangalore
Vellore
Trivandrum
Lucknow
Chandigarh
Tamil Nadu
Nairobi
Lima
Durban, KZ-Natal
E Cape
Park Town, Gauteng
Pietermaritzburg, KZ-Natal
Potchefstroom, Northwest
Pretoria, Gauteng
Kampala
Kitwe
Lusaka
Hyderabad
New Delhi
Lead Sponsor
Daiichi Sankyo
INDUSTRY